Andes Biotechnologies
PrivateLast Round
Grant
Aug 7, 2017
Total Funding Raised
$28.05M
Company Overview
Andes Biotechnologies is a drug discovery and development company that creates nucleic acid-based therapies for the treatment of solid tumor cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Andes Biotechnologies Comparables
Compare Andes Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flamingo Therapeutics | 86% | |
| Amaroq Therapeutics | 81% | |
| TransCode Therapeutics, Inc. | 79% | |
Andes Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 7, 2017 | ||||
| Series B | Apr 16, 2015 | ||||
| Series A | Sep 9, 2010 | ||||
| Series A | Mar 15, 2010 |
Andes Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Austral Capital | Series B, Series A |
| Aurus Capital | Series B, Series A |
| Austral Capital Partners | Series B, Series A |
Andes Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Andes Biotechnologies's valuation, stock price, and market status.